drug
eslicarbazepine acetate
Marketedupdated 5mo agoby Shanghai Zhongxi Pharmaceutical Co Ltd
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2all catalysts(0)
nothing on the calendar yet
Trials studying eslicarbazepine acetate
Patent cliff
source: FDA Orange Bookfirst barrier falls
Sep 13, 2028
~1.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (28)
- Aug 24, 2032method-of-use (U-2121)US 9750747
- Aug 24, 2032method-of-use (U-2041)US 9750747
- Aug 24, 2032method-of-use (U-2121)US 9750747
- Aug 24, 2032method-of-use (U-2041)US 9750747
- Apr 17, 2030formulationUS 83724313.5y
- Apr 17, 2030formulationUS 83724313.5y
- Apr 17, 2030formulationUS 83724313.5y
- Apr 17, 2030formulationUS 83724313.5y
- Oct 23, 2028formulationUS 109127812.0y
- Oct 23, 2028formulationUS 109127812.0y
- Oct 23, 2028formulationUS 109127812.0y
- Oct 23, 2028formulationUS 109127812.0y
- Oct 23, 2028formulationUS 95662442.0y
- Oct 23, 2028formulationUS 95662442.0y
- Oct 23, 2028formulationUS 95662442.0y
- Oct 23, 2028formulationUS 95662442.0y
- Sep 13, 2028method-of-use (U-2123)US 97639541.9y
- Sep 13, 2028method-of-use (U-2123)US 97639541.9y
- Sep 13, 2028method-of-use (U-2123)US 97639541.9y
- Sep 13, 2028method-of-use (U-2123)US 97639541.9y
- Apr 21, 2026compositionUS 9206135
- Apr 21, 2026compositionUS 9206135
- Apr 21, 2026compositionUS 9206135
- Apr 21, 2026compositionUS 9206135
- Apr 21, 2026formulationUS 9643929
- Apr 21, 2026formulationUS 9643929
- Apr 21, 2026formulationUS 9643929
- Apr 21, 2026formulationUS 9643929
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that